Tekla Healthcare Investors
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs funda… Read more
Tekla Healthcare Investors (HQH) - Total Assets
Latest total assets as of September 2025: $1.10 Billion USD
Based on the latest financial reports, Tekla Healthcare Investors (HQH) holds total assets worth $1.10 Billion USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Tekla Healthcare Investors - Total Assets Trend (1996–2025)
This chart illustrates how Tekla Healthcare Investors’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Tekla Healthcare Investors - Asset Composition Analysis
Current Asset Composition (September 2025)
Tekla Healthcare Investors's total assets of $1.10 Billion consist of 0.2% current assets and 99.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.0% |
| Accounts Receivable | $2.54 Million | 0.2% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1996–2025)
This chart illustrates how Tekla Healthcare Investors's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Tekla Healthcare Investors's current assets represent 0.2% of total assets in 2025, an increase from 0.2% in 1996.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2025, down from 0.2% in 1996.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1996.
- Asset Diversification: The largest asset category is accounts receivable at 0.2% of total assets.
Tekla Healthcare Investors Competitors by Total Assets
Key competitors of Tekla Healthcare Investors based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Bexil Cp
PINK:BXLC
|
USA | $29.44 Million |
|
Norte Grande
SN:NORTEGRAN
|
Chile | CL$2.91 Billion |
|
BlackRock Capital Allocation Trust
NYSE:BCAT
|
USA | $1.87 Billion |
|
Big Tech 50 R&D-Limited Partnership
TA:BIGT
|
Israel | ILA14.08 Million |
|
Zhuhai Huajin Capital Co Ltd
SHE:000532
|
China | CN¥2.38 Billion |
|
Shaanxi International Trust Co Ltd
SHE:000563
|
China | CN¥29.45 Billion |
|
Sichuan Shuangma Cement Co Ltd
SHE:000935
|
China | CN¥9.30 Billion |
|
Sk Securities
KO:001510
|
Korea | ₩7.28 Trillion |
Tekla Healthcare Investors - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Tekla Healthcare Investors generates 0.09x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Tekla Healthcare Investors generates $8.99 in net profit.
Tekla Healthcare Investors - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.43 | 34.51 | 3.95 |
| Quick Ratio | 0.43 | 34.51 | 3.95 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-791.22K | $ 38.49 Million | $ 20.45 Million |
Tekla Healthcare Investors - Advanced Valuation Insights
This section examines the relationship between Tekla Healthcare Investors's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.97 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 3.4% |
| Total Assets | $1.10 Billion |
| Market Capitalization | $179.34K USD |
Valuation Analysis
Below Book Valuation: The market values Tekla Healthcare Investors's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Tekla Healthcare Investors's assets grew by 3.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Tekla Healthcare Investors (1996–2025)
The table below shows the annual total assets of Tekla Healthcare Investors from 1996 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $1.10 Billion | +3.42% |
| 2024-09-30 | $1.06 Billion | +13.78% |
| 2023-09-30 | $932.49 Million | +0.67% |
| 2022-09-30 | $926.28 Million | -21.00% |
| 2021-09-30 | $1.17 Billion | +11.05% |
| 2020-09-30 | $1.06 Billion | +20.28% |
| 2019-09-30 | $877.78 Million | -19.14% |
| 2018-09-30 | $1.09 Billion | +1.70% |
| 2017-09-30 | $1.07 Billion | +5.73% |
| 2016-09-30 | $1.01 Billion | -9.70% |
| 2015-09-30 | $1.12 Billion | +6.04% |
| 2014-09-30 | $1.05 Billion | +52.58% |
| 2013-09-30 | $691.00 Million | +35.23% |
| 2012-09-30 | $511.00 Million | +33.91% |
| 2011-09-30 | $381.60 Million | +1.62% |
| 2010-09-30 | $375.50 Million | +2.76% |
| 2009-09-30 | $365.40 Million | -10.33% |
| 2008-09-30 | $407.50 Million | -8.37% |
| 2007-09-30 | $444.70 Million | +14.94% |
| 2006-09-30 | $386.90 Million | -7.55% |
| 2005-09-30 | $418.50 Million | +12.62% |
| 2004-09-30 | $371.60 Million | +27.48% |
| 2003-09-30 | $291.50 Million | +20.21% |
| 2002-09-30 | $242.50 Million | -26.60% |
| 2001-09-30 | $330.40 Million | -32.07% |
| 2000-09-30 | $486.40 Million | +207.46% |
| 1998-09-30 | $158.20 Million | -23.94% |
| 1997-09-30 | $208.00 Million | +40.26% |
| 1996-09-30 | $148.30 Million | -- |